WO2014202234A1 - Compositions anhydres - Google Patents

Compositions anhydres Download PDF

Info

Publication number
WO2014202234A1
WO2014202234A1 PCT/EP2014/052047 EP2014052047W WO2014202234A1 WO 2014202234 A1 WO2014202234 A1 WO 2014202234A1 EP 2014052047 W EP2014052047 W EP 2014052047W WO 2014202234 A1 WO2014202234 A1 WO 2014202234A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
carbon atoms
composition
aluminum
preferred
Prior art date
Application number
PCT/EP2014/052047
Other languages
German (de)
English (en)
Inventor
Thomas Döring
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2014202234A1 publication Critical patent/WO2014202234A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Definitions

  • the present invention relates to cosmetics, in particular anhydrous compositions which are present as shaped bodies and act as skin cosmetics.
  • Cosmetics are available in various forms of application.
  • An important form of application is solid-form cosmetics.
  • the application of cosmetics in solid form offer various advantages. Compared with a spray application or even against the application of liquid to slightly viscous compositions, solid compositions, in particular if they are present as shaped bodies, can be applied specifically to the desired location of the substrate.
  • Said solid-form cosmetics are known to the person skilled in the art, for example, as lipstick, deodorant, antiperspirant or make-up stick.
  • body odor compositions are an important part of daily personal hygiene. They should ensure that the sweat produced during the day through various activities (physical activity, work, sports) as well as psychological stress does not lead to an unpleasant body odor.
  • deodorants Just as diverse as the components of sweat and the causes of the development of body odor are the deodorants of commercial deodorants.
  • Suitable odor absorbers, fragrances, deodorizing ion exchangers, germ-inhibiting agents, prebiotic components and enzyme inhibitors can be used as cosmetic deodorizing agents.
  • Body odor is, in simplified terms, due to the bacterial decomposition of the organic components of perspiration.
  • some of the bacteria responsible for the natural microflora of human skin are responsible for bacterial degradation, especially Gram-positive anaerobic cocci, e.g. Staphylococci, such as Staphylococcus hominis, and corynebacteria.
  • Staphylococci such as Staphylococcus hominis
  • corynebacteria Since the body odor is caused by bacterial activity, it can be particularly effectively prevented by the use of cosmetic agents (soaps, creams, powders, sticks, rollers, gels or sprays) containing antimicrobial substances and perfume oil compositions.
  • antimicrobial agents triclosan and chlorhexidine are used to produce deodorants, among others.
  • essential oils such as clove oil (eugenol), peppermint oil (menthol) and thyme oil (thymol) are used as active ingredients for deodorants, although the pronounced inherent odor of these compounds has a dose-limiting effect.
  • organochlorine compound triclosan is ecologically undisputed.
  • Essential oils have a relatively high allergenic potential, which, in addition to their own odor, limits their use.
  • Aromatic alcohols such as, for example, 2-methyl-5-phenylpentan-1-ol, 2-phenylethan-1-ol or 3-phenylpropan-1-ol, are already known in the art as antimicrobial and deodorizing agents. These Compounds are highly effective, at the same time very skin-friendly, and have only a weak odor.
  • the composition When applying solid compositions to a substrate, especially when these solid form compositions are in the form of shaped bodies, the composition is rubbed on the substrate, e.g. the skin, a portion of the solid composition dissolved from the composite and deposited on the substrate.
  • the friction may cause irritation of the substrate, e.g. a skin irritation, trigger what is felt, for example, in the case of skin irritation as unpleasant.
  • the substrate is sensitive to friction, e.g. Skin (especially already irritated skin) should the solid composition have a soft and creamy texture but still be mechanically stable. This is especially true when the solid-shaped composition is present as a shaped body.
  • Solid, anhydrous composition in particular in the form of a molding, containing
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • R is a hydrocarbon radical having 5 to 19 carbon atoms.
  • Normal conditions in the context of the present application are a temperature of 20 ° C. and a pressure of 1013.25 mbar also at a pressure of 1013.25 mbar.
  • anhydrous according to the invention is understood to mean that the compositions contain 0 to a maximum of 3% by weight, preferably 0 to a maximum of 2% by weight, of free water, based on the total composition.
  • the content of water of crystallization, water of hydration or similar molecularly bound water, which in the constituents used, in particular in optionally contained antiperspirant active ingredients may be contained, does not constitute free water for the purposes of the present application.
  • the moldings according to the invention can take any geometric shape, such as concave, convex, biconcave, biconvex, cubic, tetragonal, orthorhombic, cylindrical, spherical, cylinder segment, disk-shaped, tetrahedral, dodecahedral, octahedral, conical, pyramidal, ellipsoidal, pentagonal, hexagonal, octagonal, prismatic, and rhombohedral shapes
  • Preferred moldings have a cylindrical shape, with the area of a cut made at 90 ° through the cylinder height having three to infinite corners.
  • Said cylinder section surface is particularly preferably circular or elliptical, and most preferably the shaped element has an elliptical cylinder section surface.
  • fatty alcohols are understood as meaning primary alcohols in the form of monohydroxy compounds of a linear, aliphatic hydrocarbon, said hydrocarbon having at least 12 carbon atoms and having no further substituents besides the hydroxy group.
  • composition of the invention necessarily contains a defined mixture of fatty alcohols.
  • fatty alcohols used to prepare the composition of the invention are present as a solid and all definitions relating to fatty alcohols refer to solid fatty alcohols in the context of the application and liquid fatty alcohols are attributed exclusively to the oil component of the composition according to the invention.
  • compositions have been found to be preferred, in which the term "fatty alcohol of 12 to 18 carbon atoms" refers to saturated fatty alcohol of 12 to 18 carbon atoms.
  • composition based on their total weight fatty alcohol having 12 to 18 carbon atoms in a total amount of 12 to 25 wt .-%, in particular 15 to 20 wt .-%, contains.
  • fatty alcohol of 12 to 18 carbon atoms refers to saturated fatty alcohol of 12 to 18 carbon atoms.
  • An inventively particularly preferred fatty alcohol having more than 18 carbon atoms is selected from arachidyl alcohol and / or behenyl alcohol.
  • Particularly preferred compositions are characterized in that the total amount of fatty alcohol with more than 18 carbon atoms, based on the total weight of the composition, from 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.
  • the compound according to formula (I) contained in preferred compositions of the invention carries the INCI name Meadowfoam delta-lactones.
  • compositions are characterized by a total amount of the compounds according to formula (I) of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight, based on the total weight of the composition.
  • compositions according to the invention additionally contain at least one antiperspirant active ingredient, which is also referred to as antiperspirant active ingredient.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 3 to 35% by weight, preferably 5 to 30% by weight and more preferably 10 to 23% by weight on the total weight of the anhydrous active substance (USP) in the total composition.
  • USP anhydrous active substance
  • Preferred antiperspirant active ingredients are selected from the water-soluble astringent inorganic and organic salts of aluminum, zirconium and zinc or any desired mixtures of these salts.
  • water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form.
  • antiperspirant agents are disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950.
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum and aluminum zirconium salts, which are also referred to as “enhanced activity” as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688.
  • Activated aluminum and aluminum-zirconium salts are typically produced by heat treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum and aluminum zirconium salts typically have an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks ,
  • Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated aluminum or aluminum zirconium antiperspirant salt, for example according to US 6010688, by adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups , preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups preferably propylene glycol, sorbitol and pentaerythritol
  • compositions which are described in Percent by weight contains: 18-45% by weight of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, Butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, particularly preferably propylene glycol.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant active substances are basic calcium aluminum salts, as disclosed, for example, in US Pat. No. 2,571,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6,245,325 or US 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10 and a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25.
  • USP activated aluminum or aluminum zirconium salts
  • an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10
  • a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66 75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-13% by weight of molecularly bound water (water of hydration), furthermore so much water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio 1: 1-1: 28, preferably 1: 2-1: 25, and so much glycine that the glycine to (Al + Zr) - weight ratio 2: 1-1: 20, preferably 1: 1 - 1: 10.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount to give a Sr :( Al + Zr) - weight ratio of 1: 1 - 1: 28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:1
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt, that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much hydroxyl alkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2, 1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,
  • Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 _ pb b represent Y, wherein Y is Cl, Br, I, N0 3 or S0 4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride of the formula ZrO (OH) 2 .
  • Preferred aluminum zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 1.2, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • the antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.
  • the antiperspirant active ingredients are suspended in a water-immiscible carrier, it is preferred for reasons of product stability that the active ingredient particles have a number-average particle size of 0.1 to 200 ⁇ m, preferably 1 to 50 ⁇ m, particularly preferably 3 to 20 ⁇ m, and extraordinarily preferably 5 - 10 ⁇ , have.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0.
  • water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • Aluminiumzirconiumchlorohydrat-glycine salts with Betaine are still preferred in the invention ((CH 3) 3 N + -CH 2 -COO ") are stabilized.
  • Particularly preferred corresponding compounds have a molar overall (Betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine to glycine molar ratio of at least 0.001: 1.
  • Corresponding compounds are disclosed, for example, in US 7105691.
  • a particularly effective antiperspirant salt a so-called "activated” salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 area of at least 33%, particularly preferably at least 45%, based on the total area under the peaks 2-5, measured by HPLC a 10 wt .-% strength aqueous solution of the active ingredient under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (designated peaks 2-5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content are disclosed, for example, in US 6436381 and US 6649152.
  • those activated "E 5 AZC I salts are preferred whose HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9.
  • antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • astringent titanium salts such as disclosed in GB 2299506A.
  • the antiperspirant active ingredients can be used as nonaqueous solutions or as glycolic solubilisates.
  • the composition contains a adstringie- rendes aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine or Super Ultrafine from Reheis, Microdry 323 of Summit, as Chlorhydrol ® as well as in activated form as Reach ® sold by Reheis 501 , Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred. Particular preference is also activated aluminum chlorohydrates that are available under the names Reach ® 101 and Reach ® 103 Aach 7171 by Reheis or Summit are.
  • Aluminum-zirconium-tetrachlorohydrex-glycine complexes for example, by Reheis under the name Rezal ® 36 GP of Reheis or AZG - 364 or 369 of Summit, in activated quality, as Reach ® 908, as a powder in Trade, may be particularly preferred according to the invention.
  • Aluminum-Zirkoniumpentachlorohydex-glycine complexes (AAZG-3108 or AAZG-31 10 from Summit) can also be used.
  • composition according to the invention preferably additionally contains at least one oil.
  • an oil is to be understood as meaning a liquid substance which is miscible under normal conditions in bidistilled water to less than 1% by weight.
  • composition according to the invention in each case based on the total weight of the composition - oil in a total amount of 25 to 80 Wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 40 to 60 wt.% Contains.
  • the composition according to the invention particularly preferably contains at least one volatile oil as oil.
  • the volatile oils - in each case based on the total weight of the composition - in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 30 to 55 wt .% Are contained in the composition of the invention.
  • volatile oil is understood as meaning oils having a vapor pressure of 0.01 kPa or more at 293.15 K.
  • compositions according to the invention which comprise, as volatile oil, at least one volatile silicone oil and / or at least one C 8 -C 16 -silyl paraffin.
  • Oils preferred according to the invention are selected from silicone oils, to which z.
  • Dialkyl and alkylaryl siloxanes such as cyclopentasiloxane, cyclohexasiloxane, dimethylpolysiloxane and methylphenylpolysiloxane, but also hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • volatile oils are volatile silicone oils and volatile non-silicone oils.
  • Volatile silicone oils which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopenta- siloxane and mixtures thereof, as described, for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning, are preferred according to the invention.
  • volatile linear silicone oils in particular hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ) and any mixtures of two and three of L 2 , L 3 and / or L 4 , preferably such mixtures as they z.
  • Dow Corning® 200 (0.65 cSt) and Dow Corning® 200 (1.5 cSt) from Dow Corning.
  • Volatile silicone oils are outstandingly suitable according to the invention since they give the composition according to the invention a pleasant feeling on the skin and a low level of clothes soiling.
  • Compositions which are particularly preferred according to the invention are therefore characterized by a content of at least one volatile silicone oil.
  • the volatile silicone oils based on the weight of the composition, in a total amount of from 25 to 80% by weight, particularly preferably from 30 to 70% by weight, very particularly preferably from 30 to 55% by weight, contained in the composition of the invention.
  • volatile non-silicone oil In addition to or instead of the at least one volatile silicone oil, it is also possible for at least one volatile non-silicone oil to be present.
  • Preferred volatile non-silicone oils are selected from C 8 -C 6 -isoparaffins, in particular from isodecane, isododecane, isotetradecane and isohexadecane and mixtures thereof.
  • C10-13 isoparaffin is preferred (eg commercial product Pioner 2094 from Hansen & Rosenthal). Because of the skin feel and stability of the resulting compositions, silicone oils are particularly preferred as the volatile oil over isoparaffins.
  • compositions of the present invention may additionally contain at least one non-volatile oil selected from nonvolatile silicone oils and non-volatile non-silicone oils.
  • Preferred nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for.
  • Nonvolatile silicone oils which are likewise preferred according to the invention are selected from silicones of the formula (Sil-1), where x is selected from integers of 1 to 20, preferably 1 to 3.
  • a preferred silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone.
  • Natural and synthetic hydrocarbons such as paraffin oils, Ci fine 8 -C 30 -Isoparaf-, particularly isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.
  • paraffin oils Ci fine 8 -C 30 -Isoparaf-, particularly isoeicosane, polyisobutenes or polydecenes
  • the ® for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004
  • non-volatile non-silicone oils are selected from the benzoic acid esters of linear or branched C 8 -22-alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ® TN, benzoic isostearylester, z. B. available as a commercial product Finsolv ® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ® EB, and Benzoeklareoctyldocecylester, z. B. available as a commercial product Finsolv ® BOD.
  • benzoic C12-C15 alkyl esters z. B. available as a commercial product Finsolv ® TN
  • benzoic isostearylester z. B. available as a commercial product Finsolv ® SB
  • ethylhexyl benzoate z. B. available as a commercial product Fin
  • non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 th _3 0 fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • non-volatile non-silicone oils are selected from the dicarboxylic acid esters of linear or branched C 2 -C 0 -alkanols, in particular diisopropyl propyladipat, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di- n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 2 -C 0 -alkanols in particular diisopropyl propyladipat, di-n-butyl
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or nonvolatile non-silicone oils, esters of unsaturated alkanols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated.
  • hexyldecyl stearate (Eutanol ® G 16 S), hexyldecyl laurate, isodecyl neopentanoate, Isononylisonona- noat, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868).
  • isopropyl palmitate, isopropyl stearate, isopropyl, isopropyl oleate, isooctyl, Isononylstearat, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate are, cetearyl, 2-ethylhexyl, 2-ethylhexyl, 2-ethylhexyl cocoate, 2-octyldodecyl, 2-butyl octanoic-butyl octanoate, Diisotridecylacetat , n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol diole
  • non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 -22-alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C 3 . 2 2-alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for.
  • R ' is a (C-C 6 ) alkyl group and m is an integer from 5 to 20.
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the C 8 -C 2 2 -alkanol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • esters based on linear Ci 4 / i 5 alkanols, eg. B.
  • Ci 2 -Ci 5 -alkyllactate, and of branched in 2-position Ci2 / i3-alkanols are under the trademark Cosmacol ® by Nordmann, Rassmann GmbH & Co, Hamburg, to obtain, in particular the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
  • non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with alkanols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters according to the teaching of DE 19756454 A1.
  • oils which may be preferred according to the invention are selected from the esters of dimers of unsaturated C 2 -C 2 2 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols.
  • compositions according to the invention based on the total weight of the composition, contain the nonvolatile oils in a total amount of from 0.1 to 25% by weight, in particular from 5 to 20% by weight.
  • At least one volatile oil preferably in a total amount of from 30 to 70% by weight, very particularly preferably from 30 to 55% by weight,
  • At least one non-volatile oil preferably in a total amount of 0, 1 to 25 wt .-%, in particular from 5 to 20 wt .-%.
  • composition contains at least one of the aforementioned preferred volatile oils and / or at least one of the preferred non-volatile oils.
  • compositions according to the invention are characterized in that they additionally contain at least one solid, water-insoluble particulate filler, for example for improving the consistency and the sensory properties.
  • this filler is selected from optionally modified starches (eg from corn, rice, potatoes) and starch derivatives, if desired are pre-gelatinized (eg Dry FLO PC AKZO), silica, silicas, z.
  • Aerosil ® types spherical polyalkylsesquisiloxane particles (especially Aerosil ® R972 and Aerosil ® 200V from Degussa), silica gels, talc, kaolin, magnesium aluminum silicates, boron nitride, lactoglobulin derivatives, eg. B. Sodium C 8 -i 6-lsoalkylsuccinyllactoglobulinsulfonat from Brooks Industries available as a commercial product Biopol ® OE, glass powders, polymer powders, in particular of polyolefins, polycarbonates, polyurethanes, polyamides, z.
  • nylon polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, which may be crosslinked, or silicones, and mixtures of these substances.
  • Polymer powder based on a polymethacrylate copolymer are z. B. available as a commercial product Polyrap ® 6603 (Dow Corning).
  • Other polymer powders e.g. Example based on polyamides, obtainable under the name Orgasol ® 1002 (polyamide-6) and Orgasol ® 2002 (polyamide-12) from Elf Atochem.
  • Other polymer powders which are suitable as inventively preferred fillers are, for. B.
  • compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler in a total amount of 1 to 99% by weight, preferably 2 to 90% by weight, more preferably 3 to 15% by weight, most preferably 4 , 5, 6, 7, 8, 9, 10, 1 1, 12, 13 and 14 wt .-%, each based on the total composition.
  • compositions according to the invention are therefore characterized in that they additionally contain at least one lipophilic thickener.
  • Preferred lipophilic thickeners according to the invention are selected from hydrophobized clay minerals, fumed silicas, ethylene / propylene / styrene copolymers, butylene / ethylene / styrene copolymers, dextrin esters, silicone elastomers, solid waxes under normal conditions and / or glycerol triesters.
  • the composition according to the invention additionally contains at least one silicone elastomer as the lipophilic thickener.
  • Preferred hydrophobized clay minerals are selected from hydrophobized montmorillonites, hydrophobized hectorites and hydrophobized bentonites, particularly preferably disteardimonium hectorites, stearalkonium hectorites, quaternium-18 hectorites and quaternium-18 bentonites.
  • the commercially available thickeners provide these hydrophobic clay minerals in the form of a gel in an oil component, preferably in cyclomethicones and / or a non-silicone oil component such. As propylene carbonate, ready.
  • Such gels are for example available under the trade name Bentone ® or Thixogel.
  • compositions which are preferred according to the invention are characterized in that they contain at least one hydrophobized clay mineral in a total amount of 0.5-10% by weight, preferably 1-7% by weight, more preferably 2-6% by weight, most preferably 3%. 5 wt .-%, each based on the total weight of the composition according to the invention.
  • lipophilic thickeners are selected from pyrogenic silicas, eg., the commercial products of the Aerosil ® series from Evonik Degussa. Particular preference is given to hydrophobized pyrogenic silicas, with particular preference silica silylates and silica dimethyl silylates.
  • compositions according to the invention are characterized in that they contain at least one fumed silica, preferably at least one (preferably hydrophobized) fumed silica, in a total amount of 0.5-10% by weight, preferably 1-7% by weight, more preferably 2 - 6 wt .-%, most preferably 3 - 5 wt .-%, each based on the total weight of the composition according to the invention.
  • compositions are characterized in that they contain at least one hydrophobized fumed silica and at least one hydrophilic silica.
  • lipophilic thickeners are selected from ethylene / propylene / styrene copolymers and butylene / ethylene / styrene copolymers. Particularly preferred are the copolymers used as pre-thickened oil-based gel. Such gels are, for example, under the trade name Versagel ® (ex Penreco) available. Gels with mineral oil, hydrogenated polyisobutene, isoparaffins, such as isohexadecane or isododecane, and with ester oils, in particular with isopropyl palmitate or isopropyl myristate, are preferred.
  • compositions preferred according to the invention are characterized in that they contain at least one ethylene / propylene / styrene copolymer and / or butylene / ethylene / styrene copolymer in a total amount of 0.05-3% by weight, preferably 0.1-1% by weight. , Particularly preferably 0.2 to 1, 0 wt .-%, most preferably 0.3 to 0.5 wt .-%, each based on the total weight of the composition according to the invention.
  • Further inventively preferred lipophilic thickeners are selected from silicone elastomers.
  • a further preferred embodiment of the invention is characterized in that at least one silicone elastomer which is available siloxane by the crosslinking of a Organopoly- that C 2 is at least 2 - Ci contains 0 alkenyl groups with terminal double bond in each molecule, with an organopolysiloxane containing at least 2 silicon-bonded hydrogen atoms in each molecule.
  • organopolysiloxanes having at least 2 C 2 - C 0 - alkenyl groups with terminal double bond in the molecule is selected from methylvinylsiloxanes, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylpolysiloxanes with dimethylvinylsiloxy End groups, dimethylvinylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers, Dimethylvinylsiloxy-
  • Crosslinking organopolysiloxanes having at least two silicon-bonded hydrogen atoms which are particularly preferred according to the invention are selected from trimethylsiloxy-terminated methylhydrogenpolysiloxanes, trimethylsiloxy-endblocked dimethylsiloxane-methylhydrogensiloxane copolymers and cyclic dimethylsiloxane-methylhydrogen-siloxane copolymers.
  • Silicone elastomers which are particularly preferred according to the invention and are already pre-swollen as raw material in a liquid at room temperature under normal conditions silicone and are a silicone-based gel are commercially available, for example under the trade name Dow Corning 9040 Silicone Elastomer Blend (a Cyclomethicone (and) Dimethicone Crosspolymer of Dow Corning; Silicone Elastomer Content 12-13% by Weight), SFE 168, a Cyclomethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer from GE Silicones, Vinyl Dimethicone Crosspolymers, contained in KSG-15 (Cyclomethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, Silicone elastomer content 4 - 10 wt.%), KSG-16 (dimethicone (and) dimethicone / vinyl dimethicone crosspolymer, silicone elastomer content 20-30 wt.%),
  • Gransil ® series products from the Gransil ® series, especially Gransil SR-CYC (cyclomethicone and stearyl-vinyl / hydromethylsiloxane copolymer), Gransil RPS ® gel (INCI name: Cyclopentasiloxane and Polysilicone-1 1), and ® Gransil GCM-4 (INCI name: Polysilicone-cyclotetrasiloxane and 1 1)
  • Gransil GCM-5 ® (INCI name: Cyclopentasiloxane and Polysilicone-1 1)
  • Gransil ® RPS (INCI name: Cyclopentasiloxane and Polysilicone-1 1)
  • GI-CD 10 INCI name: Cyclopentasiloxane (and) Stearoxymethicone / Dimethicone copolymer (and) Dimethicone)
  • Gransil ® IDS (INCI name: Isododecane (and
  • compositions of the present invention are silicone elastomers already present as a raw material in a silicone liquid at room temperature under normal conditions, mixed with a non-silicone-containing oil, fat or wax, and a silicone / non-silicone based Pose gel.
  • Such silicone elastomer compositions are also commercially available, for example under the trade name Gransil ® MLB (INCI name: Cyclopentasiloxane and Polysilicone-1 1 and Beeswax), Gransil ® PS (INCI name: cyclotetrasiloxane and polysilicone-1 1 and petrolatum), Gransil ® PS-5 (INCI name: Cyclopentasiloxane and Polysilicone-1 1 and Petrolatum), Gransil ® DMG-20 P with Dimethicone (20 cSt) and Petrolatum (INCI name: Dimethicone and Polysilicone-1 1 and Petrolatum), Gransil ® RJO (INCI name: Cyclopentasiloxane and polysilicone-1 1 and Jojoba Oil), Gransil ® LANO (INCI name: Cyclopentasiloxane and polysilicone-1 1 and lanolin), Gransil ® OHS-5 (INCI name
  • a further preferred embodiment of the invention is characterized in that the silicone elastomer is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C 2 -C 10 alkenyl groups having terminal double bonds in each molecule with at least one alpha, omega-diene.
  • alpha, omega-dienes are selected from 1,4-pentadiene, 1,5-hexadiene, 1,6-heptadiene, 1,7-octadiene, 1,8-nonadiene, 1,1-dodecadiene, 1,13 Tetradecadiene and 1, 19-eicosadiene.
  • compositions which are preferred according to the invention are characterized in that they contain at least one silicone elastomer in a total amount of 0.05-3% by weight, preferably 0.1-2% by weight, particularly preferably 0.2-1.0% by weight. , very preferably 0.3-0.5% by weight, based in each case on the total weight of the composition according to the invention.
  • the composition according to the invention preferably additionally contains at least one polyethylene wax.
  • Preferred polyethylene waxes have 30 to 60 carbon atoms.
  • compositions according to the invention are characterized in that they contain at least one perfume and / or at least one perfume oil.
  • perfume oils individual perfume compounds, for example the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons can be used.
  • the phenolic fragrance compounds include z. B. carvacrol.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, methyl anthranilate, ortho-t-butylcyclohexyl acetate, p-tert-butylcyclohexyl acetate, diethyl phthalate, nonanediol-1,3-diacetate, isononyl acetate, isononylate, phenylethylphenylacetate, phenoxyethyl isobutyrate, linalyl acetate, Dimethylbenzylcarbinylacetate, phenylethylacetate, linalylbenzoate, benzylformate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, ethylsalicylate, iso-amylsalicylate, hexylsalicylate and 4-non
  • the ethers include, for example, benzyl ethyl ether, to the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones, for example, 6-acetyl-1, 1, 3,4,4,6-hexamethyltetrahydronaphthalene, para-t-amylcyclohexanone, 2-n-heptyl-cyclopentanone, ⁇ -methylnaphthyl ketone and the ionones ⁇ -isomethylionone and methyl cedryl ketone, to the alcohols cinnamyl alcohol, anethole, citronellol, dimyrcetol, eugenol, geraniol , Linalool, phenylethyl alcohol
  • Suitable perfume oils may also contain natural fragrance mixtures such as are available from plant or animal sources, e.g. Pine, citrus, jasmine, rose, lily or ylang-ylang oil.
  • lower volatility volatile oils which are most commonly used as aroma components, are useful as perfume oils, e.g. Sage oil, chamomile oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, laudanum oil, clove oil, iso-eugenol, thyme oil, bergamot oil, geranium oil and rose oil.
  • compositions according to the invention comprise at least one perfume and / or at least one perfume oil in a total amount of 0.01-10% by weight, preferably 0.1-5% by weight, particularly preferably 0.5-3% by weight, extraordinarily preferably 1 to 2% by weight, in each case based on the total weight of the composition according to the invention.
  • compositions according to the invention are characterized in that they additionally contain at least one deodorant active ingredient.
  • deodorant active ingredients are selected from odor absorbers, deodorizing ion exchangers, germ-inhibiting substances, prebiotic substances and enzyme inhibitors and, particularly preferred, combinations of said deodorant active ingredients.
  • Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • the silicates which are particularly advantageous according to the invention include, in particular, phyllosilicates and, among these, in particular morillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talc.
  • Further advantageous odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll.
  • germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. These include triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride.
  • phenol disodium dihydroxyethylsulfosuccinone-undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenol sulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes a- monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably a- (2-ethylhexyl) glycerol ether, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sensiva ® SC 50 ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glycerol monolaurate, diglycerol monocaprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs that lead to a include healthy skin microflora.
  • active ingredients which are disclosed in the published patent applications DE 10333245 and DE 10 2004 01 1 968 as prebiotically effective, also included; these include conifer extracts, in particular from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts from Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular arylsulfatase, ⁇ -glucuronidase, aminoacylase, esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • compositions according to the invention are characterized in that the at least one additional deodorant active ingredient is selected from arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxygen inhibitors, ⁇ -monoalkyl glycerol ethers having a branched one or linear saturated or unsaturated, optionally hydroxylated C 6 -C 2 2-alkyl radical, in particular a- (2-ethylhexyl) glycerol ether, prebiotic active compounds, trialkylcitric acid esters, in particular triethyl citrate, active compounds which contain the number of dermal nuclei from the group staphylococci, corynebacteria, anaerococci and micrococci reduce or inhibit their growth, zinc compounds, in particular zinc phenolsulfonate and zinc ricinoleate, organohalogen compounds, in particular triclosan, chlorhexidine
  • compositions according to the invention are characterized in that the at least one additional deodorant active ingredient in a total amount of 0, 1 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 0.3 to 5 wt. %, based on the total weight of the active substance in the total composition.
  • Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development.
  • Suitable antioxidants are imidazole and imidazole derivatives (eg urocaninic acid), peptides such as e.g. B.
  • D, L-carnosine, D-carnosine, L-carnosine and their derivatives eg., Anserine
  • carotenoids eg., carotenes (eg, ⁇ -carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thio compounds (eg thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl , Propyl, amyl, butyl, lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thio
  • Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate, and carotenoids, as well as butylhydroxytoluene / anisole.
  • the total amount of antioxidants in preferred preparations according to the invention is 0.001-10% by weight, preferably 0.05-5% by weight and in particular 0.1-1% by weight, based on the total preparation.
  • Complex-forming substances can also support the deodorizing effect by stably complexing the catalytically active heavy metal ions (eg iron or copper).
  • Suitable complexing agents are selected from the aforementioned complexing agents.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • At least one antiperspirant active ingredient at least one antiperspirant active ingredient.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • the total amount of fatty alcohol having 12 to 18 carbon atoms is 12 to 25 wt .-%, in particular 15 to 20 wt .-%, and the total amount of fatty alcohol having more than 18 carbon atoms 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • one or more lactone compounds of formula I in a total amount of 0.05 to 5.0 wt .-%, in particular 0, 1 to 0.5 wt .-%,
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • the total amount of fatty alcohol having 12 to 18 carbon atoms is 12 to 25 wt .-%, in particular 15 to 20 wt .-%, and the total amount of fatty alcohol having more than 18 carbon atoms 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • one or more lactone compounds of formula I in a total amount of 0.05 to 5.0 wt .-%, in particular 0, 1 to 0.5 wt .-%,
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • Oil preferably in a total amount of from 25 to 80% by weight, particularly preferably from 30 to 70% by weight, very particularly preferably from 40 to 60% by weight,
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • one or more lactone compounds of the formula I in a total amount of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight,
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • At least one volatile oil preferably in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 30 to 55 wt.%, at least one non-volatile oil, preferably in a total amount from 0.1 to 25% by weight, in particular from 5 to 20% by weight
  • the total amount of fatty alcohol having 12 to 18 carbon atoms is 15 to 20% by weight, and the total amount of fatty alcohol having more than 18 carbon atoms is 0.005 to 1% by weight, in particular 0.05 to 0.2% by weight, is.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • At least one antiperspirant active ingredient at least one antiperspirant active ingredient.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • At least one antiperspirant active wherein the total amount of fatty alcohol having 12 to 18 carbon atoms is 12 to 25 wt .-%, in particular 15 to 20 wt .-%, and the total amount of fatty alcohol having more than 18 carbon atoms 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • one or more lactone compounds of the formula I in a total amount of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight,
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • At least one antiperspirant active at least one antiperspirant active
  • the total amount of fatty alcohol having 12 to 18 carbon atoms is 12 to 25 wt .-%, in particular 15 to 20 wt .-%, and the total amount of fatty alcohol having more than 18 carbon atoms 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • one or more lactone compounds of formula I in a total amount of 0.05 to 5.0 wt .-%, in particular 0, 1 to 0.5 wt .-%,
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • Oil preferably in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to
  • At least one antiperspirant active at least one antiperspirant active
  • the total amount of fatty alcohol having 12 to 18 carbon atoms is 15 to 20% by weight, and the total amount of fatty alcohol having more than 18 carbon atoms is 0.005 to 1% by weight, in particular 0.05 to 0.2% by weight, is.
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms, one or more lactone compounds of the formula I in a total amount of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight,
  • R is a hydrocarbon radical having 5 to 19 carbon atoms
  • At least one volatile oil preferably in a total amount of from 30 to 70% by weight, very particularly preferably from 30 to 55% by weight,
  • At least one non-volatile oil preferably in a total amount of 0, 1 to 25 wt .-%, in particular from 5 to 20 wt .-%
  • At least one antiperspirant active at least one antiperspirant active
  • the total amount of fatty alcohol having 12 to 18 carbon atoms is 15 to 20% by weight, and the total amount of fatty alcohol having more than 18 carbon atoms is 0.005 to 1% by weight, in particular 0.05 to 0.2% by weight, is.
  • a second object of the invention is a cosmetic product comprising
  • composition of the first subject of the invention located in said container.
  • composition of the first subject of the invention can be dispensed from the exit port of the dispenser by actuation of the dispensing mechanism.
  • the piston is moved and pressed the composition of the first subject of the invention in the direction of the outlet opening.
  • said composition is forced out of said dispenser through the at least one exit orifice.
  • a third object of the invention is the non-therapeutic use of a composition according to the first subject of the invention for reducing skin irritation.
  • a fourth object of the invention is the non-therapeutic use of a composition according to the first subject of the invention on irritated or sensitive skin.
  • a fifth subject of the present application is the non-therapeutic use of the additional at least one antiperspirant active containing compositions of the first subject of the invention for reducing or masking body odor.
  • a sixth article is a non-therapeutic method for treating the skin in which a composition of the first subject of the invention is applied to the skin.
  • the composition according to the invention particularly preferably remains on the skin for a time of 1 minute to 24 hours, preferably 2 to 12 hours.
  • a seventh subject matter of the present application is a non-therapeutic method of reducing or masking body odor, which comprises applying an additional at least one antiperspirant active composition of the first subject of the invention in an effective amount to the skin with a suitable applicator.
  • the composition according to the invention particularly preferably remains on the skin for a time of 1 minute to 24 hours, preferably 2 to 12 hours.
  • Solid, anhydrous composition in particular in the form of a shaped body containing
  • At least one fatty alcohol having 12 to 18 carbon atoms at least one fatty alcohol having 12 to 18 carbon atoms
  • At least one fatty alcohol with more than 18 carbon atoms at least one fatty alcohol with more than 18 carbon atoms
  • R is a hydrocarbon radical having 5 to 19 carbon atoms.
  • composition according to item 1 characterized in that in addition at least one antiperspirant active ingredient is included.
  • composition according to item 2 characterized in that antiperspirant active ingredient in a total amount of 3 to 35 wt .-%, preferably 5 to 30 wt .-% and particularly preferably 10 to 23 wt .-%, each based on the total weight the water-free active substance (USP) in the overall composition.
  • antiperspirant active ingredient in a total amount of 3 to 35 wt .-%, preferably 5 to 30 wt .-% and particularly preferably 10 to 23 wt .-%, each based on the total weight the water-free active substance (USP) in the overall composition.
  • USP water-free active substance
  • composition according to one of the items 1 to 3 characterized in that they additionally contain at least one oil
  • composition according to item 4 characterized in that, based in each case on the total weight of the composition, oil in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 40 to 60% by weight.
  • composition according to item 6 characterized in that the volatile oil is at least one volatile silicone oil and / or at least one C 8 -C 16 iso-paraffin.
  • composition according to any one of items 4 to 7, characterized in that it contains as an oil at least one compound of formula (II)
  • R ' is a (Ci-Ce) alkyl group and m is an integer from 5 to 20.
  • composition according to one of the items 1 to 8, characterized in that the total amount of fatty alcohol in each case based on the total weight of the composition is greater than 10 wt .-%, in particular greater than 15 wt .-%, is.
  • composition according to any one of items 1 to 10, characterized in that fatty alcohol containing 12 to 18 carbon atoms refers to saturated fatty alcohol containing 12 to 18 carbon atoms.
  • composition according to one of the items 1 to 14, characterized in that the total amount of the compounds according to formula (I) based on the total weight of the composition, 0.05 to 5.0 wt .-%, in particular 0.1 to 0.5 wt .-%, is.
  • Cosmetic product comprising
  • a dispensing device comprising at least one container containing a piston which serves as a wall for the container and can be moved by a dispensing mechanism (in particular a nut and spindle arrangement),
  • composition contained in said container according to any one of items 1 to 15.
  • compositions A to D were each prepared as a cylindrical antiperspirant stick. All pens had a creamy texture and could be applied to the site of action without irritating the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition anhydre sous forme solide, en particulier sous la forme d'un corps moulé, contenant au moins un alcool gras comprenant 12 à 18 atomes de carbone, au moins un alcool gras comprenant plus de 18 atomes de carbone, au moins un composé de lactone de formule (I), dans laquelle R représente un radical hydrocarbure comprenant 5 à 19 atomes de carbone. Ladite composition est appropriée en particulier pour l'application douce et non agressive sur un substrat tel que la peau.
PCT/EP2014/052047 2013-06-17 2014-02-03 Compositions anhydres WO2014202234A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013211312.9A DE102013211312A1 (de) 2013-06-17 2013-06-17 Wasserfreie Zusammensetzungen
DE102013211312.9 2013-06-17

Publications (1)

Publication Number Publication Date
WO2014202234A1 true WO2014202234A1 (fr) 2014-12-24

Family

ID=50115824

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/052047 WO2014202234A1 (fr) 2013-06-17 2014-02-03 Compositions anhydres

Country Status (2)

Country Link
DE (1) DE102013211312A1 (fr)
WO (1) WO2014202234A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11679070B2 (en) 2016-05-12 2023-06-20 L'oreal Methods for treating hair

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
BE825146A (fr) 1974-02-04 1975-08-04 Complexes d'antitranspiration
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
GB2299506A (en) 1995-04-03 1996-10-09 Unilever Plc Antiperspirant composition comprising titanium
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
DE10333245A1 (de) 2003-07-21 2005-07-28 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US20070092465A1 (en) * 2005-10-24 2007-04-26 Alan Wohlman Methods for enhancing the morphology, tone, texture and/or appearance of skin or hair using a Meadowlactone

Patent Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
BE825146A (fr) 1974-02-04 1975-08-04 Complexes d'antitranspiration
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
GB2299506A (en) 1995-04-03 1996-10-09 Unilever Plc Antiperspirant composition comprising titanium
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6074632A (en) 1997-06-25 2000-06-13 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6245325B1 (en) 1998-08-19 2001-06-12 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6649152B2 (en) 2000-10-25 2003-11-18 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 Al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
DE10333245A1 (de) 2003-07-21 2005-07-28 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US20070092465A1 (en) * 2005-10-24 2007-04-26 Alan Wohlman Methods for enhancing the morphology, tone, texture and/or appearance of skin or hair using a Meadowlactone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PUBLICATION OF ELEMENTIS: "Meadowlactone Meadowlactone Meadowlactone Meadowlactone An Effective Anti An Effective Anti An Effective Anti An Effective Anti--- -Irritant Irritant Irritant Irritant", HTTP://WWW.ESSENTIALINGREDIENTS.COM/PDF/MEADOWLACTONEANEFFECTIVEANTI-IRRITANT.PDF, 17 June 2009 (2009-06-17), online, pages 1 - 10, XP055112169, Retrieved from the Internet <URL:http://www.essentialingredients.com/pdf/MeadowlactoneAnEffectiveAnti-Irritant.pdf> [retrieved on 20140404] *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11679070B2 (en) 2016-05-12 2023-06-20 L'oreal Methods for treating hair

Also Published As

Publication number Publication date
DE102013211312A1 (de) 2014-12-18

Similar Documents

Publication Publication Date Title
EP2349184B1 (fr) Compositions de déodorant anhydres à efficacité renforcée, appliquées sans aérosol
EP2349185B1 (fr) Compositions de déodorant anhydres à efficacité renforcée, appliquées sous forme d&#39;aérosol
EP2224897B1 (fr) Sprays anti-transpirants sans eau à libération d&#39;agents améliorée
EP2480193B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d&#39;agents
EP2451426A2 (fr) Compositions cosmétiques contenant des suspensions de sels d&#39;argent
EP2931224B1 (fr) Compositions anhydres contre les odeurs corporelles
DE102009055255A1 (de) Wasserfreie Antitranspirant-Sprays mit verbesserter Leistung
EP3209267B1 (fr) Antipérspirantes ameliorées
DE102012218233A1 (de) Kosmetische Seifengelstifte mit antibakterieller Wirkung
WO2010145919A2 (fr) Compositions cosmétiques contenant du lactate d&#39;argent
EP3027167B1 (fr) Melange huile/épaississant sans eau comme fondation pour préparations cosmétiques douces, solides ou bâtons.
WO2014202234A1 (fr) Compositions anhydres
DE102012215674A1 (de) Deodorantien und/oder Antitranspirantien mit antibakterieller Wirkung
WO2014202235A1 (fr) Compositions anhydres contre les odeurs corporelles
WO2015024566A1 (fr) Antitranspirants à efficacité accrue
EP2442781A2 (fr) Compositions cosmétiques contenant du sulfate d&#39;argent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14705057

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14705057

Country of ref document: EP

Kind code of ref document: A1